Date / Time
|
Studies & Bills
|
Location
|
|
December 6, 2012
10:29 AM
|
- Bill C-44, An Act to amend the Canada Labour Code and the Employment Insurance Act and to make consequential amendments to the Income Tax Act and the Income Tax Regulations
- Marie-Adèle Davis, Executive Director (Canadian Paediatric Society)
- Stephen Moreau, Partner (Cavalluzzo Shilton McIntyre Cornish LLP)
- Denise Page, Senior Health Policy Analyst, (Canadian Cancer Society)
- Laurent Quintal, Assistant Director, Employment Insurance Policy (Human Resources and Skills Development Canada)
- Jean-François Roussy, Director, Employment Insurance Policy (Human Resources and Skills Development Canada)
|
Room 2, Victoria Building
140 Wellington Street
|
|
December 5, 2012
4:14 PM
|
- Bill C-44, An Act to amend the Canada Labour Code and the Employment Insurance Act and to make consequential amendments to the Income Tax Act and the Income Tax Regulations
- The Honourable Diane Finley, P.C., M.P., Minister of Human Resources and Skills Development
- Honourable Lisa Raitt, P.C., M.P., Minister of Labour
- Anthony Giles, Director General, Strategic Policy, Analysis and Workplace Information Directorate (Human Resources and Skills Development Canada)
- Mireille Laroche, Director General, Employment Insurance Policy (Human Resources and Skills Development Canada)
- Sue O'Sullivan, Federal Ombudsman (Office of the Federal Ombudsman for Victims of Crime)
- Michel Surprenant, Chair, Board of Directors (Association of Families of Persons Assassinated or Disappeared)
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 29, 2012
10:29 AM
|
- Bill C-313, An Act to amend the Food and Drugs Act (non-corrective contact lenses)
- Dr. Lillian Linton, President (Canadian Association of Optometrists)
- Tushar Mehta, Operations Manager (Camden Passage Inc.)
- Patricia Davidson, Member of Parliament for Sarnia-Lambton, sponsor of the bill
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 28, 2012
4:20 PM
|
- Study on prescription pharmaceuticals in Canada
|
Room 705, Victoria Building
140 Wellington Street
|
In Camera
|
November 22, 2012
10:34 AM
|
- S-204, National Strategy for Chronic Cerebrospinal Venous Insufficiency Act
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 21, 2012
4:17 PM
|
- Study on prescription pharmaceuticals in Canada
- Bruce Carleton, Professor and Co-Chair, Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia (As an individual)
- Robyn Tamblyn, Scientific Director, Research Institute, McGill University Health Centre (As an individual)
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 8, 2012
10:29 AM
|
- Study on prescription pharmaceuticals in Canada
- Françoise Baylis, Professor and Canada Research Chair, Faculty of Medicine, Dalhousie University (As an individual)
- Trudo Lemmens, Scholl Chair in Health Law and Policy, Faculty of Law, University of Toronto (As an individual)
- Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy & Management, Faculty of Health, York University (As an individual)
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 7, 2012
4:14 PM
|
- Study on prescription pharmaceuticals in Canada
- John G. Abbott, Chief Executive Officer (Health Council of Canada)
- Sylvia Hyland, Vice-President (Institute for Safe Medication Practices Canada)
- Mike Sheridan, Chief Operating Officer (Canada Health Infoway)
- Ingrid Sketris, Councillor (Health Council of Canada)
- Jennifer Zelmer, Senior Vice-President, Clinical Adoption and Innovation (Canada Health Infoway)
|
Room 2, Victoria Building
140 Wellington Street
|
|
November 1, 2012
10:29 AM
|
- S-204, National Strategy for Chronic Cerebrospinal Venous Insufficiency Act
- Dr. Andreas Laupacis, Executive Director, Li Ka Shing Knowledge Institute, St.Michael's Hospital (As an individual)
- Dr. Paolo Zamboni, Director, Vascular Diseases Centre, University of Ferrara, Italy (As an individual)
- Dr. Robert Zivadinov, Director, Buffalo Neuroimaging Analysis Centre (As an individual)
|
Room 2, Victoria Building
140 Wellington Street
|
|
October 31, 2012
4:21 PM
|
- Study on prescription pharmaceuticals in Canada
- Dr. Gerald Dal Pan, Director, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (United States Food and Drug Administration)
- Dr. Robert Temple, Deputy Center Director for Clinical Science, Center for Drug Evaluation and Research (United States Food and Drug Administration)
|
Room 2, Victoria Building
140 Wellington Street
|
|